Vir Biotechnology, Inc. (NASDAQ: VIR) is a clinical-stage immunology company headquartered in San Francisco that combines immunologic insights with modern technology platforms to treat and prevent serious infectious diseases and, increasingly, cancer. - View it on GitHub